Improvement of cocaine-induced neuromodulator deficits by the neuronutrient Tropamine.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Journal of Psychoactive Drugs

• Publication date

  1988-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1080/02791072.1988.10472501PMID 2907000
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uptake of some tritiated sympathomimetic amines by mouse brain cortex slices in vitro.

  2009cited by this paper
• Cue exposure and relapse prevention in the treatment of addictive behaviors.

  1990cited by this paper
• Cocaine alters opiate receptor binding in critical brain reward regions

  1989cited by this paper
• Angiotensin converting enzyme inhibitors: animal experiments suggest a new pharmacological treatment for alcohol abuse in humans.

  1988cited by this paper
• Cocaine influences beta-endorphin levels and release.

  1988cited by this paper
• Cerebral Blood Flow in Chronic Cocaine Users: A Study with Positron Emission Tomography

  1988cited by this paper
• Cocaine and other stimulants. Actions, abuse, and treatment.

  1988cited by this paper
• Reduction of both drug hunger and withdrawal against advice rate of cocaine abusers in a 30-day inpatient treatment program by the neuronutrient tropamine

  1988cited by this paper
• Enkephalinase inhibition and precursor amino acid loading improves inpatient treatment of alcohol and polydrug abusers: double-blind placebo-controlled study of the nutritional adjunct SAAVE.

  1988cited by this paper
• Cocaine : a clinician's handbook

  1987cited by this paper
• Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone.

  1987cited by this paper
• Enkephalinase inhibition: regulation of ethanol intake in genetically predisposed mice.

  1987cited by this paper
• Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence.

  1987cited by this paper
• Opioid peptide biosynthesis: enzymatic selectivity and regulatory mechanisms

  1987cited by this paper
• Second messengers, natural rewards, and drugs of abuse.

  1986cited by this paper
• The clinical psychopharmacology of tryptophan

  1986cited by this paper
• Clinical trial of carbidopa-L-dopa combination for cocaine abuse.

  1986cited by this paper
• Cocaine plasma concentrations in persons admitted to outpatient treatment: relationship to treatment outcome.

  1986cited by this paper
• Bromocriptine Treatment for Cocaine Abuse: The Dopamine Depletion Hypothesis

  1986cited by this paper
• Wrong diagnosis, wrong tests, wrong treatment.

  1986cited by this paper
• Bromocriptine as treatment of cocaine abuse.

  1985cited by this paper
• Neurochemical heterogeneity of the pathogenesis of epilepsy.

  1985cited by this paper
• Dopamine inhibits the release of immunoreactive beta-endorphin from rat hypothalamus in vitro.

  1985cited by this paper
• Sodium-independent binding of [3H]cocaine in mouse striatum is serotonin related

  1985cited by this paper
• Cocaine abuse: neurochemistry, phenomenology, and treatment.

  1985cited by this paper
• Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens.

  1985cited by this paper
• A brain-to-blood carrier-mediated transport system for small, N-tyrosinated peptides.

  1984cited by this paper
• Catecholamine-independent behavioral and neurochemical effects of cocaine in rats.

  1984cited by this paper
• Cocaine abuse treatment. Open pilot trial with desipramine and lithium carbonate.

  1984cited by this paper
• Cocaine and amphetamine dependence treated with desipramine.

  1983cited by this paper
• Desipramine in the treatment of hypersomnolence following abrupt cessation of cocaine use.

  1983cited by this paper
• Cocaine: comparative effect on dopamine uptake in extrapyramidal and limbic systems.

  1983cited by this paper
• Effect of cocaine on rat brain enzymes.

  1983cited by this paper
• Intraneuronal dopaminergic action of cocaine and some of its metabolites and analogs.

  1983cited by this paper
• Desipramine in the treatment of hypersomnolence following abrupt cessation of cocaine use.

  1983cited by this paper
• Cortical dopaminergic involvement in cocaine reinforcement.

  1983cited by this paper
• Naloxone potentiates cocaine effect in man.

  1982cited by this paper
• Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats.

  1982cited by this paper
• D-Phenylalanine and Other Enkephalinase Inhibitors as Pharmacological Agents: Implications for Some Important Therapeutic Application

  1982cited by this paper
• Molecular and Cell Biological Aspects of Learning: Toward a Theory of Memory

  1982cited by this paper
• D-phenylalanine and other enkephalinase inhibitors as pharmacological agents: implications for some important therapeutic application.

  1982cited by this paper
• Cocaine-induced supersensitivity of striatal dopamine receptors: role of endogenous calmodulin.

  1981cited by this paper
• Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.

  1981cited by this paper
• The use of d-phenylalanine, an enkephalinase inhibitor, in the treatment of intractable pain

  1981cited by this paper
• Post-amphetamine depression of self-stimulation responding from the substantia nigra: reversal by tricyclic antidepressants.

  1980cited by this paper
• Development of tolerance to the prolactin-releasing action of morphine and its modulation by hypothalamic dopamine.

  1980cited by this paper
• Increased dopamine receptor binding in rat brain by repeated cocaine injections.

  1979cited by this paper
• Effect of carboxypeptidase inhibition on the in vivo and in vitro pharmacological properties of morphine and enkephalins.

  1979cited by this paper
• Increased dopamine receptor binding in rat brain by repeated cocaine injections.

  1979cited by this paper
• Cocaine and D-amphetamine induce changes in central beta-adrenoceptor sensitivity: effects of acute and chronic drug treatment.

  1979cited by this paper
• A NEW ANIMAL MODEL FOR SCHIZOPHRENIA: BEHAVIORAL AND RECEPTOR BINDING STUDIES

  1979cited by this paper
• Amphetamine-type reinforcement by dopaminergic agonists in the rat

  1978cited by this paper
• Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine.

  1978cited by this paper
• β-endorphin-induced increase in striatal dopamine turnover

  1978cited by this paper
• Correlation of behavioral and neurochemical effects of acute administration of cocaine in rats.

  1978cited by this paper
• The Biochemical Basis of Neuropharmacology

  1978cited by this paper
• beta-Endorphin-induced increase in striatal dopamine turnover.

  1978cited by this paper
• Effects of methionine-enkephalin on prolactin release and catecholamine levels and turnover in the median eminence.

  1977cited by this paper
• Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine.

  1977cited by this paper
• Regulation of serotonin biosynthesis in brain: role of the high affinity uptake of tryptophan into serotonergic neurons.

  1977cited by this paper
• Neurochemical effects of cocaine following acute and repeated injection

  1977cited by this paper
• Nutrition and the brain

  1977cited by this paper
• Enkephalin may mediate euphoria and drive-reduction reward

  1977cited by this paper
• EFFECTS OF ACUTE COCAINE TREATMENT ON THE TURNOVER OF 5‐HYDROXYTRYPTAMINE IN THE RAT BRAIN

  1975cited by this paper
• Norcocaine: a pharmacologically active metabolite of cocaine found in brain.

  1974cited by this paper
• The antagonism of amphetamine-induced symptomatology by a neuroleptic.

  1974cited by this paper
• Clinical trials with amphetamine-blocking drugs.

  1972cited by this paper
• Effects of cocaine and amphetamine on the metabolism of tryptophan and 5‐hydroxytryptamine in mouse brain in vivo

  1970cited by this paper
• Modern Nutrition in Health and Disease

  1965cited by this paper
• HOMOSEXUALITY AS A CRIME.

  1965cited by this paper
• Pleasure Centers in the Brain

  1956cited by this paper

• Exercise Modifies the Brain Metabolic Response to Chronic Cocaine Exposure Inhibiting the Stria Terminalis

  2023cites this paper
• Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?

  2022cites this paper
• A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing “Precision Behavioral Management”

  2021cites this paper
• PRBM_A_292958 2115..2134

  2021cites this paper
• Pro-Dopamine Regulator – (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS)

  2017cites this paper
• Pro-Dopamine Regulator-( KB 220 ) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome ( RDS ) Mini-review

  2017cites this paper
• A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.

  2015cites this paper
• rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts

  2015cites this paper
• Low Dopamine Function in Attention Deficit/Hyperactivity Disorder: Should Genotyping Signify Early Diagnosis in Children?

  2014cites this paper
• Early Intervention of Intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (NAAT)™ Improves Behavioral Outcomes in a Residential Addiction Treatment Program: A Pilot Study

  2012cites this paper
• Kenneth Blum 1,5,6,8,10,11,12,15*, Marlene Oscar-Berman2, Elizabeth Stuller3, David Miller4,5, John Giordano6, Siobhan Morse6, Lee McCormick7, William Downs B5, Roger L Waite5, Debmalya Barh8, Dennis Neal9, Eric R Braverman1,10, Raquel Lohmann10, Joan Borsten11, Mary Hauser12, David Han13, Yijun Liu

  2012cites this paper
• Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.

  2012influential citation
• Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.

  2011cites this paper
• Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen: Proposing an Addiction Candidate Gene Panel Map

  2011cites this paper
• Overcoming qEEG Abnormalities and Reward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D2 Agonist Therapy: Part 2

  2010cites this paper
• Enhancement of Attention Processing by Kantroll™ in Healthy Humans: A Pilot Study

  1997cites this paper
• NeuRecover-SA™ in the Treatment of Cocaine Withdrawal and Craving

  1996cites this paper
• A Previous Suicide Attempt as a Factor to Predict Successful Completion of a Residential Alcohol Treatment Program

  1994cites this paper
• Measurement of locus of control in cocaine abusers.

  1992cites this paper
• Acute treatment of alcohol and cocaine emergencies.

  1992cites this paper
• Drug Abuse Treatment

  1992cites this paper
• Relapse Prevention for the Cocaine and Crack Dependent

  1992cites this paper
• Cocaine abuse treatment: a review of current strategies.

  1991cites this paper
• Medicalizing the drug war.

  1991cites this paper
• Treating crack cocaine dependence: the critical role of relapse prevention.

  1990cites this paper
• Pharmacologic approaches to the treatment of cocaine dependence.

  1990cites this paper
• Treating crack cocaine dependence: the critical role of relapse prevention.

  1990cites this paper
• The pharmacology of cocaine related to its abuse.

  1989cites this paper
• Neuroscience and Biobehavioral Reviews Reward Deficiency and Anti-reward in Pain Chronification

  year unknowncites this paper